Humacyte files Form 3 for director Scott D. Coward
HUMA•Humacyte director Scott D. Coward filed an initial Form 3 with the SEC dated Sept. 22, 2026.
1. SEC filing
Scott D. Coward, a director of Humacyte, filed an initial Form 3 with the SEC dated Sept. 22, 2026.
